Effect of Treatment with Interferon Beta-1a on Changes in Voxel-Wise Magnetization Transfer Ratio in Normal Appearing Brain Tissue and Lesions of Patients with Relapsing–Remitting Multiple Sclerosis: A 24-Week, Controlled Pilot Study

Gelijkaardige items

• Effect of treatment with interferon beta-1a on changes in voxel-wise magnetization transfer ratio in normal appearing brain tissue and lesions of patients with relapsing-remitting multiple sclerosis: a 24-week, controlled pilot study.
  door: Robert Zivadinov, et al.
  Gepubliceerd in: (2014-01-01)
• Immunologic and MRI markers of the therapeutic effect of IFN-β-1a in relapsing-remitting MS
  door: Tao, Yazhong, et al.
  Gepubliceerd in: (2015)
• Immunological and short-term brain volume changes in relapsing forms of multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: an open-label two-arm trial
  door: Dwyer, Michael G., et al.
  Gepubliceerd in: (2015)
• A pilot, longitudinal, 24-week study to evaluate the effect of interferon beta-1a subcutaneous on changes in susceptibility-weighted imaging-filtered phase assessment of lesions and subcortical deep-gray matter in relapsing–remitting multiple sclerosis
  door: Robert Zivadinov, et al.
  Gepubliceerd in: (2015-03-01)
• A pilot, longitudinal, 24-week study to evaluate the effect of interferon beta-1a subcutaneous on changes in susceptibility-weighted imaging-filtered phase assessment of lesions and subcortical deep-gray matter in relapsing–remitting multiple sclerosis
  door: Zivadinov, Robert, et al.
  Gepubliceerd in: (2015)